Home

Articles from Poxel

Poxel Reports Consolidated Revenue for the First Quarter 2025 and Provides Corporate Update
Regulatory News:
By Poxel · Via Business Wire · May 13, 2025
Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment
Regulatory News:
By Poxel · Via Business Wire · January 20, 2025
Poxel Reports Cash and Revenue for the Third Quarter and Nine Months 2024 and Provides Corporate Update
Regulatory News:
By Poxel · Via Business Wire · November 6, 2024
Poxel Reports Revenue for the First Quarter 2024 and Provides Corporate Update
Regulatory News:
By Poxel · Via Business Wire · May 16, 2024
Poxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release
Regulatory News:
By POXEL · Via Business Wire · April 29, 2024
Poxel Announces its Financial Calendar for 2024
Regulatory News:
By Poxel · Via Business Wire · January 3, 2024
Poxel Reports Cash and Revenue for the Full Year 2023 and Provides Corporate Update
Regulatory News:
By Poxel · Via Business Wire · February 15, 2024
Poxel Provides Corporate Update
Regulatory News:
By POXEL · Via Business Wire · December 21, 2023
Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023
Regulatory News:
By Poxel · Via Business Wire · November 8, 2023
Poxel Announces its Participation at Upcoming Investor Conferences
Regulatory News:
By Poxel · Via Business Wire · October 12, 2023
Poxel Announces its Participation at Upcoming Scientific Conference
Regulatory News:
By POXEL · Via Business Wire · October 2, 2023
Poxel Reports Cash and Revenue for the Second Quarter and First Half 2023 and Provides Corporate Update
Regulatory News:
By Poxel · Via Business Wire · August 30, 2023
Poxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy
Regulatory News:
By Poxel · Via Business Wire · June 15, 2023
Poxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update
Regulatory News:
By Poxel · Via Business Wire · May 17, 2023
Poxel Announces TWYMEEG® (Imeglimin) Fiscal Year 2022 Sales
Regulatory News:
By Poxel · Via Business Wire · May 15, 2023
Poxel Announces Multiple TWYMEEG® (Imeglimin) Abstracts Accepted for Oral Presentation
Regulatory News:
By Poxel · Via Business Wire · April 20, 2023
Poxel Reports Financial Results for Full Year 2022 and Provides Corporate Update
Regulatory News:
By POXEL · Via Business Wire · March 23, 2023
Poxel will Report its 2022 Full Year Results on March 23, 2023
Regulatory News:
By Poxel · Via Business Wire · March 22, 2023
Poxel Reports Cash and Revenue for the Full Year 2022 and Provides Corporate Update
Regulatory News:
By Poxel · Via Business Wire · February 15, 2023